May 17, 2017 / 5:28 PM / 2 months ago

BRIEF-Genmab announces plans for new studies of Daratumumab

1 Min Read

May 17 (Reuters) - Genmab A/S

* Genmab announces plans for new studies of daratumumab

* Genmab says 3 new phase iii studies of daratumumab planned in multiple myeloma and amyloidosis

* Genmab says studies planned to start between second half 2017 and q1 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below